Necroptosis in Cerebral Ischemia

  • Marta M. Vieira
  • Ana Luísa CarvalhoEmail author


Necroptosis is a form of regulated necrotic cell death, which is mediated by receptor-interacting protein 1 kinase (RIPK1) and RIPK3, and the downstream effector mixed lineage kinase domain-like (MLKL). Necroptotic signals induced by death receptors, such as TNF receptor 1, Toll-like receptors or interferon receptors lead to the formation of the necrosome, and result in cell death with morphological features of necrosis. The execution of necroptosis involves oligomerization of MLKL upon phosphorylation by RIPK3, its translocation to the plasma membrane and consequent plasma membrane permeabilization. Necroptosis participates in physiological functions but is also involved in cell death associated with several pathophysiological conditions. Here, we discuss key features of necroptosis, and evidence implicating necroptotic cell death in brain ischemia.


Necroptosis Brain ischemia Receptor interacting protein kinase 1/3 Mixed lineage kinase domain-like (MLKL) Necrosome 


  1. Besancon E, Guo S, Lok J, Tymianski M, Lo EH (2008) Beyond Nmda and Ampa glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 29:268–275CrossRefPubMedGoogle Scholar
  2. Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, Ward Y, Wu LG, Liu ZG (2014) Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 16:55–65CrossRefPubMedGoogle Scholar
  3. Chen X, Li W, Ren J, Huang D, He WT, Song Y, Yang C, Li W, Zheng X, Chen P, Han J (2014) Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 24:105–121CrossRefPubMedGoogle Scholar
  4. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112–1123CrossRefPubMedPubMedCentralGoogle Scholar
  5. Declercq W, Vanden Berghe T, Vandenabeele P (2009) RIP kinases at the crossroads of cell death and survival. Cell 138:229–232CrossRefPubMedGoogle Scholar
  6. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112–119CrossRefPubMedGoogle Scholar
  7. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313–321CrossRefPubMedPubMedCentralGoogle Scholar
  8. Degterev A, Zhou W, Maki JL, Yuan J (2014) Assays for necroptosis and activity of RIP kinases. Methods Enzymol 545:1–33CrossRefPubMedGoogle Scholar
  9. Ding W, Shang L, Huang JF, Li N, Chen D, Xue LX, Xiong K (2015) Receptor interacting protein 3-induced RGC-5 cell necroptosis following oxygen glucose deprivation. BMC Neurosci 16:49CrossRefPubMedPubMedCentralGoogle Scholar
  10. Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I, Hulpiau P, Weber K, Sehon CA, Marquis RW, Bertin J, Gough PJ, Savvides S, Martinou JC, Bertrand MJ, Vandenabeele P (2014) MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 7:971–981CrossRefPubMedGoogle Scholar
  11. Duprez L, Bertrand MJ, Vanden Berghe T, Dondelinger Y, Festjens N, Vandenabeele P (2012) Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. J Biol Chem 287:14863–14872CrossRefPubMedPubMedCentralGoogle Scholar
  12. Enesa K, Zakkar M, Chaudhury H, Luong Le A, Rawlinson L, Mason JC, Haskard DO, Dean JL, Evans PC (2008) NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J Biol Chem 283:7036–7045CrossRefPubMedGoogle Scholar
  13. Feng S, Yang Y, Mei Y, Ma L, Zhu DE, Hoti N, Castanares M, Wu M (2007) Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 19:2056–2067CrossRefPubMedGoogle Scholar
  14. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, Cain K, Macfarlane M, Hacker G, Leverkus M (2011) cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43:449–463CrossRefPubMedPubMedCentralGoogle Scholar
  15. Flynn RW, Macwalter RS, Doney AS (2008) The cost of cerebral ischaemia. Neuropharmacology 55:250–256CrossRefPubMedGoogle Scholar
  16. Fricker M, Vilalta A, Tolkovsky AM, Brown GC (2013) Caspase inhibitors protect neurons by enabling selective necroptosis of inflamed microglia. J Biol Chem 288:9145–9152CrossRefPubMedPubMedCentralGoogle Scholar
  17. Fujikawa DG (2015) The role of excitotoxic programmed necrosis in acute brain injury. Comput Struct Biotechnol J 13:212–221CrossRefPubMedPubMedCentralGoogle Scholar
  18. Fukui M, Choi HJ, Zhu BT (2012) Rapid generation of mitochondrial superoxide induces mitochondrion-dependent but caspase-independent cell death in hippocampal neuronal cells that morphologically resembles necroptosis. Toxicol Appl Pharmacol 262:156–166CrossRefPubMedPubMedCentralGoogle Scholar
  19. Gaither A, Porter D, Yao Y, Borawski J, Yang G, Donovan J, Sage D, Slisz J, Tran M, Straub C, Ramsey T, Iourgenko V, Huang A, Chen Y, Schlegel R, Labow M, Fawell S, Sellers WR, Zawel L (2007) A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling. Cancer Res 67:11493–11498CrossRefPubMedGoogle Scholar
  20. Galluzzi L, Kepp O, Chan FK, Kroemer G (2017) Necroptosis: mechanisms and relevance to disease. Annu Rev Pathol 12:103–130CrossRefPubMedGoogle Scholar
  21. Geserick P, Hupe M, Moulin M, Wong WW, Feoktistova M, Kellert B, Gollnick H, Silke J, Leverkus M (2009) Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 187:1037–1054CrossRefPubMedPubMedCentralGoogle Scholar
  22. Golks A, Brenner D, Fritsch C, Krammer PH, Lavrik IN (2005) c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem 280:14507–14513CrossRefPubMedGoogle Scholar
  23. Guida N, Laudati G, Serani A, Mascolo L, Molinaro P, Montuori P, Di Renzo G, Canzoniero LMT, Formisano L (2017) The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death. Biochem Pharmacol 142:229–241CrossRefPubMedGoogle Scholar
  24. Han J, Zhong CQ, Zhang DW (2011) Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol 12:1143–1149CrossRefPubMedGoogle Scholar
  25. He S, Wang L, Miao L, Wang T, Du F, Zhao L, Wang X (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137:1100–1111CrossRefPubMedGoogle Scholar
  26. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, Yuan J (2008) Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135:1311–1323CrossRefPubMedPubMedCentralGoogle Scholar
  27. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1:489–495CrossRefPubMedGoogle Scholar
  28. Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17:796–808CrossRefPubMedPubMedCentralGoogle Scholar
  29. Igney FH, Krammer PH (2002) Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2:277–288CrossRefPubMedGoogle Scholar
  30. Irrinki KM, Mallilankaraman K, Thapa RJ, Chandramoorthy HC, Smith FJ, Jog NR, Gandhirajan RK, Kelsen SG, Houser SR, May MJ, Balachandran S, Madesh M (2011) Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis. Mol Cell Biol 31:3745–3758CrossRefPubMedPubMedCentralGoogle Scholar
  31. Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, Hitomi J, Zhu H, Chen H, Mayo L, Geng J, Amin P, Dewitt JP, Mookhtiar AK, Florez M, Ouchida AT, Fan JB, Pasparakis M, Kelliher MA, Ravits J, Yuan J (2016) RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353:603–608CrossRefPubMedPubMedCentralGoogle Scholar
  32. Jagtap PG, Degterev A, Choi S, Keys H, Yuan J, Cuny GD (2007) Structure-activity relationship study of tricyclic necroptosis inhibitors. J Med Chem 50:1886–1895CrossRefPubMedGoogle Scholar
  33. Jara JH, Singh BB, Floden AM, Combs CK (2007) Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J Neurochem 100:1407–1420CrossRefPubMedPubMedCentralGoogle Scholar
  34. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T, Mocarski ES (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471:368–372CrossRefPubMedPubMedCentralGoogle Scholar
  35. Kataoka T, Schroter M, Hahne M, Schneider P, Irmler M, Thome M, Froelich CJ, Tschopp J (1998) FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J Immunol 161:3936–3942PubMedGoogle Scholar
  36. Kavuri SM, Geserick P, Berg D, Dimitrova DP, Feoktistova M, Siegmund D, Gollnick H, Neumann M, Wajant H, Leverkus M (2011) Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. J Biol Chem 286:16631–16646CrossRefPubMedPubMedCentralGoogle Scholar
  37. Kim JY, Kim YJ, Lee S, Park JH (2011) BNip3 is a mediator of TNF-induced necrotic cell death. Apoptosis 16:114–126CrossRefPubMedGoogle Scholar
  38. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S (2001) Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276:20633–20640CrossRefPubMedGoogle Scholar
  39. Li J, Mcquade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao YS, Damko E, Moquin D, Walz T, Mcdermott A, Chan FK, Wu H (2012) The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150:339–350CrossRefPubMedPubMedCentralGoogle Scholar
  40. Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS, Tran JH, Nedospasov SA, Liu ZG (2004) Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 279:10822–10828CrossRefPubMedGoogle Scholar
  41. Linkermann A, Brasen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S (2012) Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81:751–761CrossRefPubMedGoogle Scholar
  42. Lu W, Sun J, Yoon JS, Zhang Y, Zheng L, Murphy E, Mattson MP, Lenardo MJ (2016) Mitochondrial protein PGAM5 regulates mitophagic protection against cell necroptosis. PLoS One 11:e0147792CrossRefPubMedPubMedCentralGoogle Scholar
  43. Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M, Gautheron J, Roderburg C, Borg N, Reisinger F, Hippe HJ, Linkermann A, Wolf MJ, Rose-John S, Lullmann-Rauch R, Adam D, Flogel U, Heikenwalder M, Luedde T, Frey N (2014) RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res 103:206–216CrossRefPubMedGoogle Scholar
  44. Mehta SL, Manhas N, Raghubir R (2007) Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54:34–66CrossRefPubMedGoogle Scholar
  45. Meloni BP, Meade AJ, Kitikomolsuk D, Knuckey NW (2011) Characterisation of neuronal cell death in acute and delayed in vitro ischemia (oxygen-glucose deprivation) models. J Neurosci Methods 195:67–74CrossRefPubMedGoogle Scholar
  46. Miao B, Degterev A (2009) Methods to analyze cellular necroptosis. Methods Mol Biol 559:79–93CrossRefPubMedGoogle Scholar
  47. Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181–190CrossRefPubMedGoogle Scholar
  48. Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW, Briand C, Grutter MG (2002) The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 277:45162–45171CrossRefPubMedGoogle Scholar
  49. Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron 67:181–198CrossRefPubMedPubMedCentralGoogle Scholar
  50. Najafov A, Chen H, Yuan J (2017) Necroptosis and cancer. Trends Cancer 3:294–301CrossRefPubMedPubMedCentralGoogle Scholar
  51. Newton K, Dugger DL, Maltzman A, Greve JM, Hedehus M, Martin-Mcnulty B, Carano RA, Cao TC, Van Bruggen N, Bernstein L, Lee WP, Wu X, Devoss J, Zhang J, Jeet S, Peng I, Mckenzie BS, Roose-Girma M, Caplazi P, Diehl L, Webster JD, Vucic D (2016) RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ 23:1565–1576CrossRefPubMedPubMedCentralGoogle Scholar
  52. Oberst A, Dillon CP, Weinlich R, Mccormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS, Green DR (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471:363–367CrossRefPubMedPubMedCentralGoogle Scholar
  53. Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, Dewitt JP, Ye J, Zhang X, Chang A, Vakifahmetoglu-Norberg H, Geng J, Py B, Zhou W, Amin P, Berlink Lima J, Qi C, Yu Q, Trapp B, Yuan J (2015) Activation of necroptosis in multiple sclerosis. Cell Rep 10:1836–1849CrossRefPubMedPubMedCentralGoogle Scholar
  54. Olmos G, Llado J (2014) Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediat Inflamm 2014:861231CrossRefGoogle Scholar
  55. Qu Y, Shi J, Tang Y, Zhao F, Li S, Meng J, Tang J, Lin X, Peng X, Mu D (2016) MLKL inhibition attenuates hypoxia-ischemia induced neuronal damage in developing brain. Exp Neurol 279:223–231CrossRefPubMedGoogle Scholar
  56. Quarato G, Guy CS, Grace CR, Llambi F, Nourse A, Rodriguez DA, Wakefield R, Frase S, Moldoveanu T, Green DR (2016) Sequential engagement of distinct MLKL phosphatidylinositol-binding sites executes necroptosis. Mol Cell 61:589–601CrossRefPubMedPubMedCentralGoogle Scholar
  57. Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S, Ikiz B, Hoffmann L, Koolen M, Nagata T, Papadimitriou D, Nagy P, Mitsumoto H, Kariya S, Wichterle H, Henderson CE, Przedborski S (2014) Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81:1001–1008CrossRefPubMedPubMedCentralGoogle Scholar
  58. Ros U, Pena-Blanco A, Hanggi K, Kunzendorf U, Krautwald S, Wong WW, Garcia-Saez AJ (2017) Necroptosis execution is mediated by plasma membrane nanopores independent of calcium. Cell Rep 19:175–187CrossRefPubMedPubMedCentralGoogle Scholar
  59. Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, Grotta JC, Cuny GD, Yuan J, Savitz SI (2010) Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 88:1569–1576PubMedGoogle Scholar
  60. Scaffidi C, Schmitz I, Krammer PH, Peter ME (1999) The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274:1541–1548CrossRefPubMedGoogle Scholar
  61. Sun X, Yin J, Starovasnik MA, Fairbrother WJ, Dixit VM (2002) Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 277(11):9505CrossRefPubMedGoogle Scholar
  62. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, Wang X (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148:213–227CrossRefPubMedGoogle Scholar
  63. Szydlowska K, Tymianski M (2010) Calcium, ischemia and excitotoxicity. Cell Calcium 47:122–129CrossRefPubMedGoogle Scholar
  64. Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9:231–241CrossRefPubMedGoogle Scholar
  65. Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F, Zachariou A, Lopez J, Macfarlane M, Cain K, Meier P (2011) The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 43:432–448CrossRefPubMedGoogle Scholar
  66. Trichonas G, Murakami Y, Thanos A, Morizane Y, Kayama M, Debouck CM, Hisatomi T, Miller JW, Vavvas DG (2010) Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci U S A 107:21695–21700CrossRefPubMedPubMedCentralGoogle Scholar
  67. Tschopp J, Irmler M, Thome M (1998) Inhibition of fas death signals by FLIPs. Curr Opin Immunol 10:552–558CrossRefPubMedGoogle Scholar
  68. Tuuminen R, Holmstrom E, Raissadati A, Saharinen P, Rouvinen E, Krebs R, Lemstrom KB (2016) Simvastatin pretreatment reduces caspase-9 and RIPK1 protein activity in rat cardiac allograft ischemia-reperfusion. Transpl Immunol 37:40–45CrossRefPubMedGoogle Scholar
  69. Upton JW, Kaiser WJ, Mocarski ES (2010) Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7:302–313CrossRefPubMedPubMedCentralGoogle Scholar
  70. Vanden Berghe T, Van Loo G, Saelens X, Van Gurp M, Brouckaert G, Kalai M, Declercq W, Vandenabeele P (2004) Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD. J Biol Chem 279:7925–7933CrossRefGoogle Scholar
  71. Vanden Berghe T, Vanlangenakker N, Parthoens E, Deckers W, Devos M, Festjens N, Guerin CJ, Brunk UT, Declercq W, Vandenabeele P (2010) Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 17:922–930CrossRefGoogle Scholar
  72. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700–714CrossRefPubMedGoogle Scholar
  73. Vanlangenakker N, Vanden Berghe T, Bogaert P, Laukens B, Zobel K, Deshayes K, Vucic D, Fulda S, Vandenabeele P, Bertrand MJ (2011) cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ 18:656–665CrossRefPubMedGoogle Scholar
  74. Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187:1477–1485CrossRefPubMedPubMedCentralGoogle Scholar
  75. Vieira M, Fernandes J, Carreto L, Anuncibay-Soto B, Santos M, Han J, Fernandez-Lopez A, Duarte CB, Carvalho AL, Santos AE (2014) Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3. Neurobiol Dis 68:26–36CrossRefPubMedGoogle Scholar
  76. Vosler PS, Sun D, Wang S, Gao Y, Kintner DB, Signore AP, Cao G, Chen J (2009) Calcium dysregulation induces apoptosis-inducing factor release: cross-talk between PARP-1- and calpain-signaling pathways. Exp Neurol 218:213–220CrossRefPubMedPubMedCentralGoogle Scholar
  77. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680–1683CrossRefPubMedGoogle Scholar
  78. Wang K, Li J, Degterev A, Hsu E, Yuan J, Yuan C (2007) Structure-activity relationship analysis of a novel necroptosis inhibitor, necrostatin-5. Bioorg Med Chem Lett 17:1455–1465CrossRefPubMedGoogle Scholar
  79. Wang Z, Jiang H, Chen S, Du F, Wang X (2012) The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148:228–243CrossRefPubMedGoogle Scholar
  80. Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, Wang FS, Wang X (2014a) Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 54:133–146CrossRefPubMedGoogle Scholar
  81. Wang Y, Wang H, Tao Y, Zhang S, Wang J, Feng X (2014b) Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury. Neuroscience 266:91–101CrossRefPubMedGoogle Scholar
  82. Weinlich R, Dillon CP, Green DR (2011) Ripped to death. Trends Cell Biol 21:630–637CrossRefPubMedPubMedCentralGoogle Scholar
  83. Xu Y, Wang J, Song X, Qu L, Wei R, He F, Wang K, Luo B (2016) RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF. Sci Rep 6:29362CrossRefPubMedPubMedCentralGoogle Scholar
  84. Yamanaka K, Saito Y, Yamamori T, Urano Y, Noguchi N (2011) 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis. J Biol Chem 286:24666–24673CrossRefPubMedPubMedCentralGoogle Scholar
  85. Yang QH, Du C (2004) Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J Biol Chem 279:16963–16970CrossRefPubMedGoogle Scholar
  86. Yin B, Xu Y, Wei RL, He F, Luo BY, Wang JY (2015) Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury. Brain Res 1609:63–71CrossRefPubMedGoogle Scholar
  87. You Z, Savitz SI, Yang J, Degterev A, Yuan J, Cuny GD, Moskowitz MA, Whalen MJ (2008) Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 28:1564–1573CrossRefPubMedPubMedCentralGoogle Scholar
  88. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo MJ (2004) Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304:1500–1502CrossRefPubMedGoogle Scholar
  89. Yuan L, Wang Z, Liu L, Jian X (2015) Inhibiting histone deacetylase 6 partly protects cultured rat cortical neurons from oxygenglucose deprivationinduced necroptosis. Mol Med Rep 12:2661–2667CrossRefPubMedPubMedCentralGoogle Scholar
  90. Zang D, Shao Y, Li X (2013) Ultrastructural pathology of rat lung injury induced by ischemic acute kidney injury. Ultrastruct Pathol 37:433–439CrossRefPubMedGoogle Scholar
  91. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, Dong MQ, Han J (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325:332–336CrossRefPubMedGoogle Scholar
  92. Zhang M, Li J, Geng R, Ge W, Zhou Y, Zhang C, Cheng Y, Geng D (2013) The inhibition of ERK activation mediates the protection of necrostatin-1 on glutamate toxicity in HT-22 cells. Neurotox Res 24:64–70CrossRefPubMedGoogle Scholar
  93. Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, Liu ZG (2012) Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A 109:5322–5327CrossRefPubMedPubMedCentralGoogle Scholar
  94. Zhao H, Ning J, Lemaire A, Koumpa FS, Sun JJ, Fung A, Gu J, Yi B, Lu K, Ma D (2015) Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats. Kidney Int 87:738–748CrossRefPubMedGoogle Scholar
  95. Zheng W, Degterev A, Hsu E, Yuan J, Yuan C (2008) Structure-activity relationship study of a novel necroptosis inhibitor, necrostatin-7. Bioorg Med Chem Lett 18:4932–4935CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Receptor Biology SectionNational Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesdaUSA
  2. 2.Department of Life Sciences, CNC—Center for Neuroscience and Cell BiologyUniversity of CoimbraCoimbraPortugal

Personalised recommendations